Basis: FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The Price/FCF ratio is N/A as of 2026-10-06T15:28:02.768Z.
Calculation as of: 2026-10-06T15:28:02.768Z.
Quote observation: 2026-10-06T15:22:47.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 733e4da94f9494cd21c7af02f5120fd8528014c079e3dffba0957966aae51245
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2019-08-12.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PRICE/FCF RATIO
N/A
PRICE/FCF RATIO AVG TTM
N/A
PRICE/FCF RATIO AVG 3Y
N/A
PRICE/FCF RATIO AVG 5Y
N/A
PRICE/FCF RATIO AVG 10Y
N/A
PRICE/FCF RATIO AVG 15Y
N/A
PRICE/FCF RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$18.73M
Price/FCF Ratio
N/A
TTM Avg
126.35
3Y Avg
822.33
5Y Avg
822.33
Market Cap
$19.20M
Price/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | PRICE/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| NextCure, Inc. (NXTC) | $18.67M | N/A | N/A | N/A | N/A |
| Neuphoria Therapeutics Inc. (NEUP)vs › | $18.73M | N/A | 126.35 | 822.33 | 822.33 |
| Estrella Immunopharma, Inc. (ESLA)vs › | $19.20M | N/A | N/A | N/A | N/A |
| P3 Health Partners Inc. (PIII)vs › | $19.72M | N/A | N/A | N/A | N/A |
| Actuate Therapeutics Inc (ACTU)vs › | $19.86M | N/A | N/A | N/A | N/A |
| Cosmos Health Inc. (COSM)vs › | $17.28M | N/A | 14.41 | 40.25 | 40.25 |
| PAVmed Inc. (PAVM)vs › | $17.21M | N/A | N/A | N/A | N/A |
| Lipocine Inc. (LPCN)vs › | $17.19M | N/A | N/A | N/A | N/A |
| Marker Therapeutics, Inc. (MRKR)vs › | $17.09M | N/A | N/A | N/A | N/A |
| Bionano Genomics, Inc. (BNGO)vs › | $16.58M | N/A | N/A | N/A | N/A |
P/FCF Ratio
N/A
FCF Yield
N/A
P/FCF measures market price relative to free cash flow per share. Free cash flow is operating cash flow after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | PRICE/FCF RATIO |
|---|---|
| 2019-08-12 | 252.34 |
| 2019-08-09 | 248.90 |
| 2019-08-08 | 237.04 |
| 2019-08-07 | 254.01 |
| 2019-08-06 | 240.68 |
| 2019-08-05 | 224.34 |
| 2019-08-02 | 229.54 |
| 2019-08-01 | 231.62 |
| 2019-07-31 | 228.71 |
| 2019-07-30 | 217.67 |
| 2019-07-29 | 213.93 |
| 2019-07-26 | 205.81 |
| 2019-07-25 | 205.60 |
| 2019-07-24 | 200.08 |
| 2019-07-23 | 194.04 |
| 2019-07-22 | 201.33 |
| 2019-07-19 | 198.73 |
| 2019-07-18 | 182.70 |
| 2019-07-17 | 171.77 |
| 2019-07-16 | 169.48 |
| 2019-07-15 | 172.49 |
| 2019-07-12 | 174.68 |
| 2019-07-11 | 177.08 |
| 2019-07-10 | 173.33 |
| 2019-07-09 | 176.45 |
| 2019-07-08 | 163.75 |
| 2019-07-05 | 173.12 |
| 2019-07-03 | 175.83 |
| 2019-07-02 | 178.01 |
| 2019-07-01 | 183.74 |
| 2019-06-28 | 155.94 |
| 2019-06-27 | 147.41 |
| 2019-06-26 | 149.90 |
| 2019-06-25 | 149.28 |
| 2019-06-24 | 151.57 |
| 2019-06-21 | 152.20 |
| 2019-06-20 | 157.92 |
| 2019-06-19 | 160.52 |
| 2019-06-18 | 161.56 |
| 2019-06-17 | 157.40 |
| 2019-06-14 | 161.67 |
| 2019-06-13 | 162.08 |
| 2019-06-12 | 150.84 |
| 2019-06-11 | 160.84 |
| 2019-06-10 | 381.99 |
| 2019-06-07 | 404.96 |
| 2019-06-06 | 406.92 |
| 2019-06-05 | 397.14 |
| 2019-06-04 | 432.83 |
| 2019-06-03 | 424.03 |
| 2019-05-31 | 455.07 |
| 2019-05-30 | 468.75 |
| 2019-05-29 | 448.22 |
| 2019-05-28 | 481.95 |
| 2019-05-24 | 486.35 |
| 2019-05-23 | 478.28 |
| 2019-05-22 | 485.86 |
| 2019-05-21 | 489.04 |
| 2019-05-20 | 504.43 |
| 2019-05-17 | 483.90 |
| 2019-05-16 | 493.19 |
| 2019-05-15 | 489.04 |
| 2019-05-14 | 476.08 |
| 2019-05-13 | 474.13 |
| 2019-05-10 | 476.57 |
| 2019-05-09 | 486.35 |
